droxidopa has been researched along with entacapone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, DS; Holmes, C; Kopin, IJ; Pechnik, S; Sewell, L | 1 |
| Endo, T; Fukada, K; Hamasaki, T; Hazama, T; Sakoda, S; Yokoe, M | 1 |
2 trial(s) available for droxidopa and entacapone
| Article | Year |
|---|---|
Effects of carbidopa and entacapone on the metabolic fate of the norepinephrine prodrug L-DOPS.
Topics: Aged; Antiparkinson Agents; Blood Pressure; Carbidopa; Catechols; Double-Blind Method; Droxidopa; Drug Interactions; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Nitriles; Norepinephrine; Parkinson Disease; Prodrugs; Pure Autonomic Failure; Vasoconstriction | 2011 |
L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson's disease.
Topics: Adult; Aged; Catechol O-Methyltransferase Inhibitors; Catechols; Droxidopa; Drug Therapy, Combination; Gait Ataxia; Humans; Japan; Middle Aged; Nitriles; Parkinson Disease; Treatment Outcome | 2013 |